Scientific article

Gentamicin inactivation in purulent exudates: role of cell lysis

Published inThe Journal of infectious diseases, vol. 142, no. 4, p. 586-593
Publication date1980

Factors contributing to the binding and reversible inactivation of gentamicin by purulent exudates were studied in a simplified in vitro model consisting of purified human polymorphonuclear leukocytes (PMNLs). Whereas intact PMNLs (10(6)-10(8)/ml) bound almost no [14C]gentamicin, freeze-thawed PMNLs showed extensive [14C]gentamicin binding, expressed as antibiotic cosedimenting with particulate material from the lysed PMNLs. Antibiotic binding could be related to the concentration of lysed PMNLs and to the amount of [14C]gentamicin added. Binding of [14C]gentamicin by lysed PMNLs was highly sensitive to DNase I but was unaffected by RNase, Triton X-100, or protease. Purified chromatin or DNA from either purulent exudates or lysed PMNLs reproduced the [14C]gentamicin-binding pattern obtained with crude PMNL lysate. These results show that gentamicin inactivation in purulent exudates can be correlated with binding of the antibiotic to lysed PMNLs; PMNL chromatin DNA is identified as one of the major binding factors.

  • Aminoglycosides/antagonists & inhibitors
  • Binding Sites
  • Cell Survival
  • Dna
  • Drug Resistance, Microbial
  • Exudates and Transudates/ microbiology
  • Gentamicins/ antagonists & inhibitors
  • Humans
  • Neutrophils
Citation (ISO format)
VAUDAUX, Pierre, WALDVOGEL, Francis. Gentamicin inactivation in purulent exudates: role of cell lysis. In: The Journal of infectious diseases, 1980, vol. 142, n° 4, p. 586–593. doi: 10.1093/infdis/142.4.586
Main files (1)
ISSN of the journal0022-1899

Technical informations

Creation06/21/2010 10:26:58 AM
First validation06/21/2010 10:26:58 AM
Update time03/14/2023 3:46:02 PM
Status update03/14/2023 3:46:02 PM
Last indexation02/12/2024 6:39:19 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack